A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. (Q40561912)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

main subject

phase I clinical trial

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

J D Rosenblatt

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D M Sahasrabudhe

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Evans

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Ladrigan

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D Marquis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Rosell

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

T Whiteside

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Phillippe

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

B Acres

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Slos

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

P Squiban

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M Ross

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K Kendra

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

251-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

HLA-class-I and -class-II expression on renal tumor xenografts and the relation to sensitivity for alpha-IFN, gamma-IFN and TNF.

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Histocompatibility antigens on murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

The Cell Biology of Macrophage Activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Constitutive transduction of peptide transporter and HLA genes restores antigen processing function and cytotoxic T cell-mediated immune recognition of human melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Tumor cell responses to IFNgamma affect tumorigenicity and response to IL-12 therapy and antiangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Interferon-gamma in the first-line therapy of ovarian cancer: a randomized phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Induction of melanoma-associated antigen systemic immunity upon intratumoral delivery of interferon-gamma retroviral vector in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Response of resting human peripheral blood natural killer cells to interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Interleukin-2 augments natural killer cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

In vitro and in vivo regulation of human tumor antigen expression by human recombinant interferons: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

Regression of primary hepatocarcinoma in cancer-prone transgenic mice by local interferon-gamma delivery is associated with macrophages recruitment and nitric oxide production

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

1 reference

7 January 2021

A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

In vivo effects of combination treatment with recombinant interferon-gamma and -alpha in metastatic melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

Interferon-gamma in healthy subjects: selective modulation of inflammatory mediators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

Combination immunotherapy for cancer: synergistic antitumor interactions of interleukin-2, alfa interferon, and tumor-infiltrating lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

Coexpression of IL-2 and gamma-IFN enhances tumor immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700568

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700568

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12679797%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 November 2019

1003110134

0 references

1 reference